Putman Léon M, van Gameren Menno, Meijboom Folkert J, de Jong Peter L, Roos-Hesselink Jolien W, Witsenburg Maarten, Takkenberg Johanna J M, Bogers Ad J J C
Department of Cardio-Thoracic Surgery, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.
Eur J Cardiothorac Surg. 2009 Jul;36(1):96-104; discussion 104. doi: 10.1016/j.ejcts.2009.01.046. Epub 2009 Mar 20.
With a growing number of children with congenital heart disease (CHD) reaching adulthood, an extensive experience with cardiac surgery in adults with CHD is accumulating. To increase insight in this patient category we report our 17-year single centre experience including predictors for adverse outcome and EuroSCORE performance.
Patients and operative characteristics of all consecutive adult CHD patients operated upon between January 1990 and January 2007 were collected. Categorisation was done according to the EACTS/STS congenital database. Early and late morbidity and mortality were assessed with follow-up extending up to 17 years. EuroSCORE performance was assessed.
Nine hundred and sixty-three procedures were performed in 830 patients (mean age 39.3 years, 50.3% male). A total of 49% were re-do procedures, frequent procedures were for left heart lesions (37%), right heart lesions (31%) and septal defects (8%). The 51% primary procedures largely consisted of less complex procedures but also included 1.4% of tetralogy of Fallot repairs, 4.1% of aortic coarctation repairs and 2.7% of Ebstein's disease repairs. Thirty-day mortality was 1.5% (n=14); predicted mortality by logistic EuroSCORE was 4.6%. c-index was 0.61 (95% CI 0.46-0.75). Major complications such as tamponade requiring intervention occurred in 3.2%, postoperative bleeding requiring re-exploration in 7.1% and renal insufficiency requiring dialysis in 4 (0.4%). Pulmonary hypertension was a strong predictor for short-term mortality; impaired ventricular function and cyanosis for long-term mortality. Overall 17-year survival was 71% (95% CI 61%-82%). Eighty percent of patients were in NYHA class I at last follow-up, 17% in II, 3% in III, 0% in IV.
Surgery in adult CHD patients can be performed with low operative mortality and good clinical outcome. EuroSCORE is not a good model for risk assessment in this group of patients.
随着越来越多的先天性心脏病(CHD)患儿长大成人,成人先天性心脏病心脏手术的经验日益丰富。为了更深入了解这类患者,我们报告了我们17年的单中心经验,包括不良结局的预测因素和欧洲心脏手术风险评估系统(EuroSCORE)的表现。
收集1990年1月至2007年1月期间所有连续接受手术的成人先天性心脏病患者的患者及手术特征。根据欧洲心胸外科学会/胸外科医师学会先天性数据库进行分类。通过长达17年的随访评估早期和晚期发病率及死亡率。评估欧洲心脏手术风险评估系统的表现。
830例患者共进行了963例手术(平均年龄39.3岁,男性占50.3%)。其中49%为再次手术,常见手术类型为左心病变(37%)、右心病变(31%)和间隔缺损(8%)。51%的初次手术大多为不太复杂的手术,但也包括1.4%的法洛四联症修复术、4.1%的主动脉缩窄修复术和2.7%的埃布斯坦畸形修复术。30天死亡率为1.5%(n = 14);逻辑EuroSCORE预测死亡率为4.6%。c指数为0.61(95%可信区间0.46 - 0.75)。需要干预的主要并发症如心包填塞发生率为3.2%,需要再次探查的术后出血发生率为7.1%,需要透析的肾功能不全发生率为4例(0.4%)。肺动脉高压是短期死亡率的强预测因素;心室功能受损和发绀是长期死亡率的预测因素。总体17年生存率为71%(95%可信区间61% - 82%)。最后一次随访时,80%的患者纽约心脏协会(NYHA)心功能分级为I级,17%为II级,3%为III级,0%为IV级。
成人先天性心脏病患者手术可实现较低的手术死亡率和良好的临床结局。EuroSCORE不是这类患者风险评估的良好模型。